Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works

Current Perspectives on Statins

Maron, D. J., Fazio, S., & Linton, M. F. (2000) · Circulation · doi:10.1161/01.cir.101.2.207 · Cited by 1,217 · see citing works

Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.

Jones, P., Kafonek, S., Laurora, I., & Hunninghake, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00965-x · Cited by 1,067 · see citing works

Air Force/Texas Coronary Atherosclerosis Prevention Study

佐々木, 淳. (2008) · Japanese journal of clinical medicine · Cited by 411 · see citing works

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., & Capuzzi, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.056 · Cited by 315 · see citing works

Outcomes in 45 Patients With Statin-Associated Myopathy

Hansen, K. E., Hildebrand, J. P., Ferguson, E. E., & Stein, J. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2671 · Cited by 280 · see citing works

Recent Trends in Use of Herbal and Other Natural Products

Kelly, J. P. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.281 · Cited by 278 · see citing works

Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial

Becker, D. J., Gordon, R. Y., Halbert, S. C., French, B., Morris, P. B., & Rader, D. J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00006 · Cited by 275 · see citing works

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials.

Liu, J., Zhang, J., Shi, Y. P., Grimsgaard, S., Alræk, T., & Fønnebø, V. M. (2006) · Chinese Medicine · doi:10.1186/1749-8546-1-4 · Cited by 236 · see citing works

Tolerability of Red Yeast Rice (2,400 mg Twice Daily) Versus Pravastatin (20 mg Twice Daily) in Patients With Previous Statin Intolerance

Halbert, S. C., French, B., Gordon, R. Y., Farrar, J. T., Schmitz, K., Morris, P. B., Thompson, P. D., Rader, D. J., & Becker, D. J. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.08.672 · Cited by 154 · see citing works

Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia

Lin, C., Li, T., & Lai, M.-M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02012 · Cited by 150 · see citing works

Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia

Davidson, M. H., Toth, P. D., Weiss, S. R., McKenney, J. M., Hunninghake, D., Isaacsohn, J. L., Donovan, J. M., & Burke, S. K. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240610 · Cited by 103 · see citing works

The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders

Yang, C., & Mousa, S. A. (2012) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2012.07.004 · Cited by 76 · see citing works

Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products

Chen, C.-H., Yang, J., Uang, Y., & Lin, C. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.028 · Cited by 75 · see citing works

HypoCol (red yeast rice) lowers plasma cholesterol – a randomized placebo controlled study

Bogsrud, M. P., Ose, L., Langslet, G., Ottestad, I. O., Strøm, E., Hagve, T., & Retterstøl, K. (2010) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431003624123 · Cited by 73 · see citing works

Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)

Li, J., Lu, Z., Kou, W., Chen, Z., Wu, Y., Yu, X.-H., Zhao, Y., & on behalf of the Chinese Coronary Secondary Prevention Study (CCSPS) Group (2010) · Annals of Medicine · doi:10.3109/07853891003652534 · Cited by 48 · see citing works

Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease

Zhao, S., Liu, L., Cheng, Y.-C., & Li, Y.-L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00142-4 · Cited by 47 · see citing works

Effects of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina

Li, J., Hu, S., Fang, C., Hui, R.-T., Miao, L., Yang, Y., & Gao, R. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.09.026 · Cited by 45 · see citing works

Xuezhikang, An Extract of Cholestin, Reduces Cardiovascular Events in Type 2 Diabetes Patients With Coronary Heart Disease: Subgroup Analysis of Patients With Type 2 Diabetes From China Coronary Secondary Prevention Study (CCSPS)

Zhao, S., Lu, Z., Du, B., Chen, Z., Wu, Y., Yu, X.-H., Zhao, Y., Liu, L., Ye, H.-J., & Wu, Z. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31802d3a58 · Cited by 39 · see citing works

Plasma Clearance of Lovastatin Versus Chinese Red Yeast Rice in Healthy Volunteers

Li, Z., Seeram, N. P., Lee, R., Thames, G., Minutti, C., Wang, H.-J., & Heber, D. (2005) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2005.11.1031 · Cited by 33 · see citing works

Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X

Li, J., Wang, Y., Nie, S., Li, Q., Li, Y., Huang, Y., & Hui, R. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.11.031 · Cited by 28 · see citing works

Long-Term Effects of Xuezhikang on Blood Pressure in Hypertensive Patients with Previous Myocardial Infarction: Data from the Chinese Coronary Secondary Prevention Study (CCSPS)

Li, J., Lu, Z., Kou, W., Chen, Z., Wu, Y., Yu, X.-H., & Zhao, Y. (2010) · Clinical and Experimental Hypertension · doi:10.3109/10641961003686427 · Cited by 19 · see citing works

Effects of Withdrawal of Xuezhikang, an Extract of Cholestin, on Lipid Profile and C-reactive Protein: A Short-Term Time Course Study in Patients with Coronary Artery Disease

Hu, C.-L., Li, Y., Tang, Y., Chen, J.-B., Liu, J., Tang, Q., Zhang, Q., & Huang, C. Y. (2006) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-006-7947-x · Cited by 13 · see citing works

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: A post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Li, J.-J., Lu, Z.-L., Kou, W., Bolli, R., Chen, Z., Wu, Y.-F., Yu, X.-H., & Zhao, Y. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.005 · Cited by 11 · see citing works

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272 · see citing works

Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – A systematic review and meta-analysis

Gerards, M. C., Terlou, R. J., Yu, H., Koks, C. H. W., & Gerdes, V. E. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.04.004 · Cited by 169 · see citing works

Treatment of atherosclerosis by traditional Chinese medicine: Questions and quandaries

Wang, C., Niimi, M., Watanabe, T., Wang, Y., Liang, J., & Fan, J. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.039 · Cited by 164 · see citing works

Major achievements of evidence-based traditional Chinese medicine in treating major diseases

Chao, J., Dai, Y., Verpoorte, R., Lam, W., Cheng, Y., Pao, L., Zhang, W., & Chen, S. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.123 · Cited by 157 · see citing works

Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials

Fogacci, F., Banach, M., Mikhailidis, D. P., Bruckert, É., Toth, P. P., Watts, G. F., Reiner, Ž., Mancini, J., Rizzo, M., Mitchenko, O., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.028 · Cited by 132 · see citing works

National lipid association annual summary of clinical lipidology 2016

Bays, H. E., Jones, P. H., Orringer, C. E., Brown, W. V., & Jacobson, T. A. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.002 · Cited by 128 · see citing works

Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons

Patel, S. V. (2016) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-016-2035-2 · Cited by 89 · see citing works

Statin-associated muscle symptoms—Managing the highly intolerant

Backes, J. M., Ruisinger, J. F., Gibson, C., & Moriarty, P. M. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.01.006 · Cited by 88 · see citing works

Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system

Mazzanti, G., Moro, P. A., Raschi, E., Da Cas, R., & Menniti‐Ippolito, F. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13171 · Cited by 81 · see citing works

National Lipid Association Annual Summary of Clinical Lipidology 2015

Bays, H. E., Jones, P. H., Brown, W. V., & Jacobson, T. A. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.10.002 · Cited by 81 · see citing works

Quality Markers of Traditional Chinese Medicine: Concept, Progress, and Perspective

Li, Y., Xie, Y., He, Y., Hou, W., Liao, M., & Liu, C. (2019) · Engineering · doi:10.1016/j.eng.2019.01.015 · Cited by 73 · see citing works

Red Yeast Rice for the Treatment of Dyslipidemia

Burke, F. M. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0495-8 · Cited by 73 · see citing works

Monascus purpureus-fermented common buckwheat protects against dyslipidemia and non-alcoholic fatty liver disease through the regulation of liver metabolome and intestinal microbiome

Huang, Z., Chen, M., Guo, W., Li, T., Liu, B., Bai, W., Ai, L., Rao, P., Ni, L., & Lv, X. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109511 · Cited by 63 · see citing works

Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention

Heinz, T., Schuchardt, J. P., Möller, K., Hadji, P., & Hahn, A. (2016) · Nutrition Research · doi:10.1016/j.nutres.2016.07.005 · Cited by 54 · see citing works

Quality and Authenticity Control of Functional Red Yeast Rice—A Review

Song, J., Luo, J., Ma, Z., Sun, Q., Wu, C., & Li, X. (2019) · Molecules · doi:10.3390/molecules24101944 · Cited by 53 · see citing works

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review

Cicero, A. F. G., Fogacci, F., Stoian, A. P., & Toth, P. P. (2023) · Nutrients · doi:10.3390/nu15102288 · Cited by 47 · see citing works

MediterrAsian Diet Products That Could Raise HDL-Cholesterol: A Systematic Review

Rondanelli, M., Giacosa, A., Morazzoni, P., Guido, D., Grassi, M., Morandi, G., Bologna, C., Riva, A., Allegrini, P., & Perna, S. (2016) · BioMed Research International · doi:10.1155/2016/2025687 · Cited by 37 · see citing works

Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials

Li, P., Wang, Q., Chen, K., Zou, S., Shu, S., Lu, C., Wang, S., Jiang, Y., Fan, C.-X., & Luo, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.819482 · Cited by 36 · see citing works

Comprehensive chemical profiling of monascus-fermented rice product and screening of lipid-lowering compounds other than monacolins

Liang, J., Zhang, Q.-Q., Huang, Y., Pang, H., Liu, X., Gao, W. Y., Li, P., & Yang, H. Q. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111879 · Cited by 28 · see citing works

Traditional Chinese medicine for lipid metabolism disorders.

Li, Y., Wang, X., & Shen, Z. (2017) · Europe PMC (PubMed Central) · Cited by 28 · see citing works

Xuezhikang, an extract from red yeast rice, attenuates vulnerable plaque progression by suppressing endoplasmic reticulum stress-mediated apoptosis and inflammation

Shen, L., Sun, Z., Chu, S., Cai, Z., Nie, P., Wu, C., Yuan, R., Hu, L., & He, B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188841 · Cited by 25 · see citing works

Xuezhikang improves the outcomes of cardiopulmonary resuscitation in rats by suppressing the inflammation response through TLR4/NF-κB pathway

Liang, L., Shao, W., Shu, T., Zhang, Y., Xu, S. B., Guo, L., Zhou, Y., Huang, H., & Sun, P. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108817 · Cited by 25 · see citing works

Original Research

Peng, D., Fong, A., & van Pelt, A. (2017) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000521973.38717.2e · Cited by 24 · see citing works

Impact of red yeast rice supplementation on lipid profile: a systematic review and meta-analysis of randomized-controlled trials

Rahmani, P., Melekoğlu, E., Tavakoli, S., Alamdari, N. M., Rohani, P., & Sohouli, M. H. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2138342 · Cited by 22 · see citing works

Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review

Bagherniya, M., Johnston, T. P., & Sahebkar, A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200427092114 · Cited by 21 · see citing works

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway

Zhao, S., Li, R., Dai, W., Yu, B., Chen, L.-Z., & Huang, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184949 · Cited by 19 · see citing works

Efficacy of Chinese herbal medicine for stroke modifiable risk factors: a systematic review

Peng, W., Lauche, R., Ferguson, C., Frawley, J., Adams, J., & Sibbritt, D. W. (2017) · Chinese Medicine · doi:10.1186/s13020-017-0146-9 · Cited by 17 · see citing works

Nonalcoholic Fatty Liver Disease as an Emerging Risk Factor and Potential Intervention Target for Atherosclerotic Cardiovascular Diseases

Zhang, D., Mi, Z., Peng, J., Yang, T., Han, Y., Zhai, Y., Song, C., Teng, X., Sun, W., Guo, J., et al. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001418 · Cited by 17 · see citing works

Effects of Xuezhitong in Patients with Hypertriglyceridemia: a Multicentre, Randomized, Double-Blind, Double Simulation, Positive Drug and Placebo Parallel Control Study

Jia, W., Li, Y., Wan, J., Cui, X., Lu, J., Liu, J., Li, D., Li, L., Zou, T., Ding, J., et al. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06965-3 · Cited by 16 · see citing works

Statin intolerance and new lipid-lowering treatments

Mesi, O., Lin, C., Ahmed, H. M., & Cho, L. S. (2021) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.20165 · Cited by 14 · see citing works

Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database

Chen, T.-L., Lin, C., Lin, J., Yeh, C.-C., Sung, L., Chang, Y., Shih, C.-C., & Liao, C. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s223833 · Cited by 14 · see citing works

Coronary Artery Disease

Simone, R. D. (1994) · Springer eBooks · doi:10.1007/978-3-642-78956-4_5 · Cited by 14 · see citing works

A systematic, updated review of Xuezhikang, a domestically developed lipid-lowering drug, in the application of cardiovascular diseases

Yang, C. Y., Wu, Y., Qian, J., & Li, J. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.05.011 · Cited by 13 · see citing works

The current trend and challenges of developing red yeast rice-based food supplements for hypercholesterolemia

Chen, G., Chen, W., Jin-hong, X., Ma, G., Hu, X., & Chen, G. (2023) · Journal of Future Foods · doi:10.1016/j.jfutfo.2023.03.003 · Cited by 13 · see citing works

Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy

Liu, H., Li, X., Dong, Y., Zhou, C., & Rezeng, C. (2023) · Journal of Cancer · doi:10.7150/jca.86683 · Cited by 13 · see citing works

Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis

Zhang, H., Wu, J., Zhang, Z., Qian, H., Wang, Y., Yang, M., Cheng, Y., & Tang, S. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s204860 · Cited by 12 · see citing works

Red yeast rice (Monascus purpureus) supplements: Case series assessment of spontaneously reported cases to The Netherlands Pharmacovigilance Centre Lareb

Vrolijk, M. F., van de Koppel, S., & van Hunsel, F. P. A. M. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14599 · Cited by 12 · see citing works

Long-Term Effect of Zhenzhu Tiaozhi Capsule (FTZ) on Hyperlipidemia: 2-Year Results from a Retrospective Study Using Electronic Medical Records

Huang, X., Zhan, H., Yang, J. M., Peng, L., Piao, S., Wang, L., Lan, T., Rong, X., & Guo, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6264414 · Cited by 10 · see citing works

Novel findings in relation to multiple anti‐atherosclerotic effects of XueZhiKang in humans

Xu, R., Zhang, Y., Guo, Y., Ma, C., Yao, Y., Li, S., Li, X., Qing, P., Gao, Y., Wu, N., et al. (2017) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2017.09.004 · Cited by 10 · see citing works

The effect of Xuezhikang capsule on gene expression profile in brown adipose tissue of obese spontaneously hypertensive rats

Zhang, S., Jiang, Y., Wang, X., Zhang, H., Gu, P., Gong, Z., Jiang, W., Zhang, Y., & Zhu, Y. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115700 · Cited by 9 · see citing works

Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial

Dai, L., Zhong, L. L. D., Cao, Y., Chen, W., Cheng, Y., Lin, X., Bian, Z., & Lü, A. (2016) · Trials · doi:10.1186/s13063-016-1419-9 · Cited by 7 · see citing works

Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patients with T2DM and Dyslipidemia: Study Protocol for a Multicenter Randomized Controlled Trial

Xu, J. Q., Zhu, L., Xie, Y., Zhang, M., Xiao, Z., Su, R., Wen, T., & Liu, L. (2023) · Current Vascular Pharmacology · doi:10.2174/1570161121666230328110215 · Cited by 6 · see citing works

Future of red yeast rice: a promising and safer natural approach for daily management of hypercholesterolemia

Ma, G., Hu, X., Jin-hong, X., Yang, F., Chen, J.-G., & Chen, G. (2025) · Food & medicine homology. · doi:10.26599/fmh.2026.9420092 · Cited by 6 · see citing works

Efficacy and safety assessment of traditional Chinese patent medicine for dyslipidemia: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis

Fang, Y., Wu, H., Liang, X., Li, T., Jia, R., Dong, Y., Zheng, Y., Wang, Q., & Li, L. (2024) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-24-146 · Cited by 4 · see citing works

Treatment of Hypertriglyceridemia: A Review of Therapies in the Pipeline

Xu, J., & Ashjian, E. J. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211053489 · Cited by 4 · see citing works

Efficacy and safety of xuezhikang once per day versus two times per day in patients with mild to moderate hypercholesterolaemia (APEX study): a protocol for a multicentre, prospective randomised controlled, open-label, non-inferiority study

Wu, Z., Wu, D., Jiang, J., Chen, A., Zheng, D.-D., Li, J., Dong, Y., & Chen, Y. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034585 · Cited by 3 · see citing works

Decreased Risk of Stroke in People Using Red Yeast Rice Prescriptions (LipoCol Forte®): a Total Population-Based Retrospective Cohort Study

Chang, C., Sun, M.-F., Chou, Y., Yeh, C., Hu, C., Cherng, Y., Chen, T.-L., & Liao, C. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8160425 · Cited by 3 · see citing works

Role of Dietary Nutrition, Vitamins, Nutrients, and Supplements in Cardiovascular Health

Moran, R. J., Davis, M. G., & Maletz, A. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_1 · Cited by 3 · see citing works

Coronary Artery Disease

Devries, S. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00026-8 · Cited by 3 · see citing works

Cost-effectiveness of dietary supplement ingredients versus generic statins for LDL reduction

White, C. M., Sedensky, A., Sicignano, D. J., & Galli, K. J. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100428 · Cited by 2 · see citing works

Monakolina — pomost między prozdrowotną modyfikacją diety a farmakoterapią hipercholesterolemii

Wożakowska−Kapłon, B., & Salwa, P. (2016) · Folia Cardiologica · doi:10.5603/fc.2016.0044 · Cited by 2 · see citing works

Fungus Monascus-Fermented Red Yeast Rice (RYR): Natural Therapeutic Statin Source or Mycotoxin?

Patel, S. V., & Akhtar, N. (2018) · Springer eBooks · doi:10.1007/978-981-13-0393-7_38 · Cited by 2 · see citing works

Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study

Chang, C., Yeh, C.-C., Tiong, C., Sun, M.-F., Lin, J.-G., Cherng, Y., Chen, T.-L., & Liao, C. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s466696 · Cited by 1 · see citing works

Chinese patent medicine for atherosclerosis: a systematic review and Meta-analysis of randomized controlled trials.

Jian, X. U., Yuntao, L., Zhihao, L., Zhao, Z. W., Wang, D., & Qing, L. (2024) · PubMed Central · doi:10.19852/j.cnki.jtcm.2024.06.001 · Cited by 1 · see citing works

S.A.M. and Breast Cancer—Focus on Statins, Red Yeast Rice, Sterols, and Other Integrative Cholesterol Medicines: The Real “Natural” Options

Moyad, M. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-23422-9_4

Elucidating the mechanism by which regulating spleen and lipid method improves the state of hyperlipidaemic ratsPreprint

Liu, G., Pan, L., Sun, Q., & Wang, S. (2019) · doi:10.21203/rs.2.19568/v1

Effects of Xuezhikang vs. Pravastatin on Triglyceride Level in Patients with Type 2 Diabetes Mellitus and Dyslipidemia: A Research Protocol for a Randomized Controlled StudyPreprint

Xu, J., Du, X., Zhang, S., Xiang, Q., Guo, L., Zhu, L., Tan, Y., Fu, Y., Xie, Y., Zhang, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-871652/v1

The Facts About High Density Lipoprotein Cholesterol (HDL-C). I'm Pretty Good Within Limits

Bheemanaboina, G., Deverashetty, J. R., & Bashetti, S. (2023) · Acta Scientifci Nutritional Health · doi:10.31080/asnh.2023.07.1232

Non-alcoholic-Related Fatty Liver Disease (NAFLD) as a Risk Factor for Atherosclerotic Cardiovascular Disease: The Hidden Link – ASCVD Risk Factors from NAFLD

Bilonda, K. P. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009971

Protective Effects of Red Yeast Rice and the Associated Preparations on Gut Microbiota Against Atherosclerosis

Jia, F., Xu, J., Zhou, M., & Mao, Y. (2026) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr46345

Xuezhikang Capsule ameliorates ischemic stroke via multi-target modulation of neurovascular units

Zhang, X., Hou, C., Wang, Y., Chen, Y., Li, L., Xue, L., Hao, C., Liu, X., & Zeng, K. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.05.010

The Efficacy and Safety of Zanghongqu Herbal Slices in the Treatment of Hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo controlled clinical trialPreprint

Zhang, Y., Wei, J., Wang, A., Li, B., Yu, R., Qiao, L., Xing, Y., Wang, X., Li, X., & Zhu, M. (2026) · Research Square · doi:10.21203/rs.3.rs-9524517/v1

White hyacinth bean polysaccharide mitigates high-fat diet-induced myocardial injury by modulating the gut microbiota-phenylalanine-heart axis in mice

Chen, J., Gui, Y., Lu, S., Li, Y., Chen, X., Peng, X., & Li, W. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107516

Does receiving red yeast rice prescriptions (LipoCol Forte®) increase the risk of end-stage renal disease or not? A retrospective cohort study

Chang, C.-C., Lam, F., Yeh, C.-C., Lin, J.-G., Chen, T.-L., & Liao, C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0345243

Familial hypercholesterolaemia in the genomic era: improving the clinical utility of current genetic testing

Knowles, C., Hills, A., Watson, E., Pennock, M., Dent, C. E., Evans, J. C., Robinson, C., Woodward, G., Wadsley, M. K., Honeychurch, J., et al. (2018) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2018.07.027

A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia

Shang, Q., Liu, Z., Chen, K., Xu, H., & Liu, J. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/636547 · Cited by 78 · see citing works

Xuezhikang Capsule for Hyperlipidemia: A Systematic Review

Chen, K. (2006) · Zhongguo xunzheng yixue zazhi · Cited by 5 · see citing works

Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease

Zhu, L., Wen, X.-Y., Xiang, Q., Guo, L., Xu, J. R., Zhao, S., & Liu, L. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.674446 · Cited by 8 · see citing works

doi:10.1155/2012/636547 Review Article A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia

Shang, Q., Liu, Z., Chen, K., Xu, H., & Liu, J. (2012)